Stock Research for NURO

NURO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NURO Stock Chart & Research Data

The NURO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NURO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NURO Due diligence Resources & Stock Charts

The NURO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NURO Detailed Price Forecast - CNN Money CNN View NURO Detailed Summary - Google Finance
Yahoo View NURO Detailed Summary - Yahoo! Finance Zacks View NURO Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View NURO Trends & Analysis - Trade-Ideas Barrons View NURO Major Holders - Barrons
NASDAQ View NURO Call Transcripts - NASDAQ Seeking View NURO Breaking News & Analysis - Seeking Alpha
Spotlight View NURO Annual Report - CompanySpotlight.com OTC Report View NURO OTC Short Report - OTCShortReport.com
TradeKing View NURO Fundamentals - TradeKing Charts View NURO SEC Filings - Bar Chart
WSJ View Historical Prices for NURO - The WSJ Morningstar View Performance/Total Return for NURO - Morningstar
MarketWatch View the Analyst Estimates for NURO - MarketWatch CNBC View the Earnings History for NURO - CNBC
StockMarketWatch View the NURO Earnings - StockMarketWatch MacroAxis View NURO Buy or Sell Recommendations - MacroAxis
Bullish View the NURO Bullish Patterns - American Bulls Short Pains View NURO Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View NURO Stock Mentions - StockTwits PennyStocks View NURO Stock Mentions - PennyStockTweets
Twitter View NURO Stock Mentions - Twitter Invest Hub View NURO Investment Forum News - Investor Hub
Yahoo View NURO Stock Mentions - Yahoo! Message Board Seeking Alpha View NURO Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for NURO - SECform4.com Insider Cow View Insider Transactions for NURO - Insider Cow
CNBC View NURO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NURO - OTC Markets
Yahoo View Insider Transactions for NURO - Yahoo! Finance NASDAQ View Institutional Holdings for NURO - NASDAQ


Stock Charts

FinViz View NURO Stock Insight & Charts - FinViz.com StockCharts View NURO Investment Charts - StockCharts.com
BarChart View NURO Stock Overview & Charts - BarChart Trading View View NURO User Generated Charts - Trading View




Latest Financial News for NURO


NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year
Posted on Wednesday April 24, 2024

Key Insights NeuroMetrix to hold its Annual General Meeting on 30th of April CEO Shai Gozani's total compensation...


NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
Posted on Friday April 19, 2024

Joshua S. Horowitz joins Board of DirectorsAt-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders, Ephraim Fields of Echo Lake Capital. The Board has approved the appointment of Joshua S. Horowitz as a new independent director with a 1-year term. Mr. Horowitz is a professional investor with over 22


NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
Posted on Thursday March 14, 2024

WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck alone accurately detects diabetic peripheral neuropathy (DPN). Hayashi and colleagues evaluated 167 patients with Type 1 or Type 2 diabetes. The reference standard for DPN was a gold standard nerve conduction study. The authors developed a predictive formula based on DPNCheck measurements, patient age


NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
Posted on Wednesday March 13, 2024

WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022. “We have been pleased by the positive response to Quell Fibromyalgia from providers taking care of patients with fibromyalgia during our strategic launch phase,” said Shai N. Gozani, M.D., Ph.D., Chief Executive Officer of NeuroMetrix. “This early adoption affirms the


Stock Market & Investing Books

Enter a stock symbol to view the stock details.